Lund Arthritis Research Group (LARG)
11 – 20 of 106
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Second and third TNF inhibitors in European patients with axial spondyloarthritis : effectiveness and impact of the reason for switching
(
- Contribution to journal › Article
-
Mark
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis : a European routine-care observational study
(
- Contribution to journal › Article
-
Mark
Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy : results from the ICEBIO registry
(
- Contribution to journal › Article
-
Mark
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
(
- Contribution to journal › Article
-
Mark
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
(
- Contribution to journal › Article
-
Mark
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis : results from nine European rheumatology registries
(
- Contribution to journal › Article
-
Mark
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate : Are They Interchangeable?
(
- Contribution to journal › Article
-
Mark
High leptin levels in blood are associated with chronic widespread pain in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries : A survey
(
- Contribution to journal › Article
-
Mark
Pneumococcal vaccine in adults with immune-mediated inflammatory diseases
(
- Contribution to journal › Debate/Note/Editorial